IN BRIEF: Spire Healthcare "pleased" with trading so far this year

Spire Healthcare Group PLC - London-based healthcare company - Says it is "pleased to confirm that performance in the period has been in line with our expectations and the 2025 guidance provided". Adds that its "on-going transformation programme" remains on track with the benefits seen as weighted towards the second half of 2025. Says it expects the programme to deliver "at least" GBP30 million in "efficiencies" this year. Furthermore, Spire confirms that due to having 100% direct UK revenue exposure, it does not currently expect recent tariff announcements to cause any material cost or supply chain impacts. Finally, Spire says it was recently named a founding supplier as part of the UK government's National Strategic Supplier Relationship programme, adding: "We look forward to working with the NHS to build a strong, long term and sustainable footing for increased NHS commissioning."

Current stock price: 197.60 pence, up 1.1% in London on Wednesday

12-month change: down 24%

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Spire Healthcare